Cumberland Pharmaceuticals Inc. (CPIX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 59.53M |
| Enterprise Value | 58.26M |
| P/E Ratio | 1.13 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 3.16 |
| Price/Book Ratio | 1.1 |
| Enterprise/Revenue | 0.14 |
| Enterprise/EBITDA | -0.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 2.75 |
| Operating Margin | -0.35 |
| Return On Assets | 0.61 |
| Return On Equity | 2.03 |
| Revenue | 44.52M |
| Revenue/Share | 1.68 |
| Gross Profit | 37.85M |
| EBITDA | 2.96M |
| Net Income | -2.84M |
| Diluted EPS | -0.19 |
| Total Cash | 80.58M |
| Total Cash/Share | 5.38 |
| Total Debt | 4.6M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.05 |
| Book Value Per Share | 4.81 |
| 52-Week Change | 165 |
| 52-Week High | 9.28 |
| 52-Week Low | 1.85 |
| Moving Average 50 Days | 6.66 |
| Moving Average 200 Days | 5.54 |
| Average Volume | 92,196 |
| Shares Outstanding | 14.98M |
| % Held by Institutions | 16.48 |
| Trailing Annual Dividend Rate | 1.5 |
| Trailing Annual Dividend Yield | 28.3 |
| Payout Ratio | 0.33 |
| Last Split Factor | N/A |
| Last Split Date | N/A |